BSPK
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Aug 26 closing price
Capitalization
2.17M
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.12B
Interact to see
Advertisement

BSPK vs CHSYF

Header iconBSPK vs CHSYF Comparison
Open Charts BSPK vs CHSYFBanner chart's image
Bespoke Extracts
Price$0.19
Change-$0.00 (-0.00%)
Volume$5.68K
Capitalization2.17M
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.12B
BSPK vs CHSYF Comparison Chart in %
Loading...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSPK vs. CHSYF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSPK is a Buy and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (BSPK: $0.19 vs. CHSYF: $1.35)
Brand notoriety: BSPK and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BSPK: 13% vs. CHSYF: 49%
Market capitalization -- BSPK: $2.17M vs. CHSYF: $4.12B
BSPK [@Pharmaceuticals: Generic] is valued at $2.17M. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.12B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.9B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSPK’s FA Score shows that 0 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • BSPK’s FA Score: 0 green, 5 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than BSPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSPK’s TA Score shows that 5 TA indicator(s) are bullish while CHSYF’s TA Score has 0 bullish TA indicator(s).

  • BSPK’s TA Score: 5 bullish, 4 bearish.
  • CHSYF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, BSPK is a better buy in the short-term than CHSYF.

Price Growth

BSPK (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.12B) has a higher market cap than BSPK($2.17M). BSPK YTD gains are higher at: 220.576 vs. CHSYF (45.052). CHSYF has higher annual earnings (EBITDA): 1.77B vs. BSPK (-1M). CHSYF has more cash in the bank: 6.04B vs. BSPK (21.4K). BSPK has less debt than CHSYF: BSPK (1.16M) vs CHSYF (1.14B). CHSYF has higher revenues than BSPK: CHSYF (7.01B) vs BSPK (1.08M).
BSPKCHSYFBSPK / CHSYF
Capitalization2.17M4.12B0%
EBITDA-1M1.77B-0%
Gain YTD220.57645.052490%
P/E RatioN/A14.11-
Revenue1.08M7.01B0%
Total Cash21.4K6.04B0%
Total Debt1.16M1.14B0%
FUNDAMENTALS RATINGS
BSPK vs CHSYF: Fundamental Ratings
BSPK
CHSYF
OUTLOOK RATING
1..100
2740
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
10045
PRICE GROWTH RATING
1..100
3740
P/E GROWTH RATING
1..100
10077
SEASONALITY SCORE
1..100
n/a16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (14) in the null industry is significantly better than the same rating for BSPK (96). This means that CHSYF’s stock grew significantly faster than BSPK’s over the last 12 months.

CHSYF's Profit vs Risk Rating (94) in the null industry is in the same range as BSPK (100). This means that CHSYF’s stock grew similarly to BSPK’s over the last 12 months.

CHSYF's SMR Rating (45) in the null industry is somewhat better than the same rating for BSPK (100). This means that CHSYF’s stock grew somewhat faster than BSPK’s over the last 12 months.

BSPK's Price Growth Rating (37) in the null industry is in the same range as CHSYF (40). This means that BSPK’s stock grew similarly to CHSYF’s over the last 12 months.

CHSYF's P/E Growth Rating (77) in the null industry is in the same range as BSPK (100). This means that CHSYF’s stock grew similarly to BSPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSPKCHSYF
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
17%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
9%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
9%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
6%
View a ticker or compare two or three
Interact to see
Advertisement
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AROW29.760.42
+1.43%
Arrow Financial Corp
EPAC42.370.45
+1.07%
Enerpac Tool Group Corp
ALTO1.150.01
+0.88%
Alto Ingredients
YMM13.10-0.11
-0.83%
Full Truck Alliance Co Ltd
INDP4.61-0.79
-14.63%
Indaptus Therapeutics Inc

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
AVCNF - BSPK
9%
Poorly correlated
-1.29%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
N/A
CANN - CHSYF
7%
Poorly correlated
+8.98%
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
CANQF - CHSYF
-0%
Poorly correlated
N/A
More